Company news
|
28 December 2015 Alkor Bio Group's Laboratory of Allergology has launched 18 new allergensAlkor Bio Group's Laboratory of Allergology completed the development and transferred to the production 18 new allergens for in vitro allergen diagnostics. Thus, today Alkor Bio Group produces 555 allergens, including 17 allergen components. |
25 November 2015 Alkor Bio Group has developed and launched 22 new allergens for in vitro allergy diagnostics, including two allergen componentsAlkor Bio Group's Laboratory of Allergology completed the development and transferred to the production 22 new allergens, including two allergen components. |
24 November 2015 Alkor Bio Group has developed test systems for scientific epidemiological studies that allows to differentiate subtypes of human herpesvirus 6In October The Molecular Diagnostics Laboratory of Alkor Bio Group completed development of the diagnostic kit "Intifika HHV6A / HHV6B» intended for definition of subtypes A and B of human herpesvirus 6 (HHV6). |
|
28 September 2015 Alkor Bio Group of Companies has confirmed its compliance with international QMS standards ISO 9001:2008 and ISO13485:2003On September, Alkor Bio Group of Companies has been assessed for compliance with the International standards ISO 9001 and ISO 13485.
|
28 September 2015 Alkor Bio Group have transferred the European production of TORCH infections diagnostic kitsIn September 2015, Alkor Bio Group have announced successful transfer of technologies from Europe. |
14 September 2015 Alkor Bio Group has launched 16 new allergens, including 8 drug allergensAlkor Bio Group's Laboratory of Allergology transferred to the production 27 new allergens, including 8 drug allergens at the first half of September. |